8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
May 4, 2026·SEC
Material company update
Feb 25, 2026·SEC
Innoviva, Inc.(INVA)Earnings, Financials & Key Ratios
INVA•NASDAQ
$22.52
$1.91B mkt cap·6.8× P/E·Price updated May 6, 2026
AboutInnoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.Show more
- Revenue$425M+18.5%
- EBITDA$204M+5.8%
- Net Income$271M+1059.2%
- EPS (Diluted)3.30+816.7%
- Gross Margin72.33%-19.4%
- EBITDA Margin47.98%-10.7%
- Operating Margin38.52%-17.2%
- Net Margin63.78%+878.1%
- ROE29.09%+749.6%
- ROIC14.21%+0.4%
- Debt/Equity0.23-64.9%
- Interest Coverage20.57+666.7%
INVA Key Insights
Innoviva, Inc. (INVA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 20.5%
- ✓FCF machine: 46.1% free cash flow margin
- ✓Healthy 5Y average net margin of 52.1%
✗Weaknesses
- ✗Shares diluted 14.3% in last year
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
INVA Price & Volume
Innoviva, Inc. (INVA) stock price & volume — 10-year historical chart
Loading chart...
INVA Growth Metrics
Innoviva, Inc. (INVA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years22.93%
5 Years4.77%
3 Years8.66%
TTM13.61%
Profit CAGR
10 Years-
5 Years3.86%
3 Years8.22%
TTM944.46%
EPS CAGR
10 Years-
5 Years10.31%
3 Years11.67%
TTM683.1%
Return on Capital
10 Years30.91%
5 Years19.33%
3 Years12.32%
Last Year12.36%
INVA Recent Earnings
Innoviva, Inc. (INVA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 10/12 qtrs (83%)
Q1 2026Latest
Feb 25, 2026EPS
$1.94
Est $0.34
+470.6%
Revenue
$115M
Est $103M
+11.7%
Q4 2025
Nov 5, 2025EPS
$1.08
Est $0.46
+134.8%
Revenue
$108M
Est $102M
+6.2%
Q3 2025
Aug 6, 2025EPS
$0.77
Est $0.57
+35.1%
Revenue
$100M
Est $91M
+10.3%
Q2 2025
May 7, 2025EPS
$0.25
Est $0.29
-13.8%
Revenue
$89M
Est $83M
+7.2%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 25, 2026 | $1.94vs $0.34+470.6% | $115Mvs $103M+11.7% |
| Q4 2025 | Nov 5, 2025 | $1.08vs $0.46+134.8% | $108Mvs $102M+6.2% |
| Q3 2025 | Aug 6, 2025 | $0.77vs $0.57+35.1% | $100Mvs $91M+10.3% |
| Q2 2025 | May 7, 2025 | $0.25vs $0.29-13.8% | $89Mvs $83M+7.2% |
Based on last 12 quarters of dataView full earnings history →
INVA Peer Comparison
Innoviva, Inc. (INVA) competitors in Royalty and IP Monetization Vehicles — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PRGO | 1.69B | 12.26 | -1.19 | -2.75% | -43.5% | -50.65% | 1.35 | |
 GSK | 101.62B | 50.53 | 6.69 | 4.11% | 19.19% | 31.48% | 1.11 | |
 AZN | 286.68B | 184.92 | 28.28 | 8.63% | 17.19% | 22.24% | 0.61 | |
 TEVA | 42.31B | 36.34 | 30.28 | 4.31% | 9.02% | 20.69% | 2.20 | |
 AMRN | 309.92M | 14.90 | -8.28 | -6.55% | -15.64% | -7.34% | 0.03 | |
 INCY | 19.95B | 99.85 | 15.58 | 21.22% | 26.71% | 29.31% | 0.01 | |
 ABBV | 362.56B | 204.98 | 86.49 | 8.57% | 6.91% | 62.15% | ||
 MRK | 280.48B | 113.56 | 15.60 | 1.18% | 28.12% | 36.14% | 0.96 |
Compare INVA vs Peers
Innoviva, Inc. (INVA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
INVA Income Statement
Innoviva, Inc. (INVA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 217.22M | 261M | 261.02M | 336.79M | 391.87M | 331.34M | 310.46M | 358.71M | 425.13M | 424.12M |
| Revenue Growth % | 62.63% | 20.16% | 0% | 29.03% | 16.35% | -15.45% | -6.3% | 15.54% | 18.52% | 13.61% |
| Cost of Goods Sold | 1.35M | 0 | 0 | 0 | 0 | 13.79M | 42.64M | 36.6M | 117.61M | 100.96M |
| COGS % of Revenue | 0.62% | - | - | - | - | 4.16% | 13.73% | 10.2% | 27.67% | - |
| Gross Profit | 215.86M▲ 0% | 261M▲ 20.9% | 261.02M▲ 0.0% | 336.79M▲ 29.0% | 391.87M▲ 16.4% | 317.55M▼ 19.0% | 267.82M▼ 15.7% | 322.11M▲ 20.3% | 307.52M▼ 4.5% | 323.16M▲ 0% |
| Gross Margin % | 99.38% | 100% | 100% | 100% | 100% | 95.84% | 86.27% | 89.8% | 72.33% | 76.2% |
| Gross Profit Growth % | 63.31% | 20.91% | 0% | 29.03% | 16.35% | -18.97% | -15.66% | 20.27% | -4.53% | - |
| Operating Expenses | 32.26M | 22.75M | 14.66M | 15.67M | 16.76M | 110.55M | 153.94M | 155.25M | 143.77M | 260.19M |
| OpEx % of Revenue | 14.85% | 8.72% | 5.62% | 4.65% | 4.28% | 33.36% | 49.58% | 43.28% | 33.82% | - |
| Selling, General & Admin | 32.26M | 17.05M | 14.66M | 13.88M | 16.19M | 63.54M | 98.23M | 115.69M | 113.17M | 118.33M |
| SG&A % of Revenue | 14.85% | 6.53% | 5.62% | 4.12% | 4.13% | 19.18% | 31.64% | 32.25% | 26.62% | - |
| Research & Development | 1.35M | 0 | 0 | 1.79M | 576K | 41.43M | 33.92M | 13.65M | 30.6M | 31.45M |
| R&D % of Revenue | 0.62% | - | - | 0.53% | 0.15% | 12.5% | 10.93% | 3.81% | 7.2% | - |
| Other Operating Expenses | -1.35M | 5.7M | 0 | 0 | 0 | 5.58M | 21.78M | 25.9M | 0 | 2M |
| Operating Income | 183.6M▲ 0% | 238.25M▲ 29.8% | 246.36M▲ 3.4% | 321.12M▲ 30.3% | 375.1M▲ 16.8% | 207M▼ 44.8% | 113.89M▼ 45.0% | 166.87M▲ 46.5% | 163.75M▼ 1.9% | 62.97M▲ 0% |
| Operating Margin % | 84.53% | 91.28% | 94.38% | 95.35% | 95.72% | 62.47% | 36.68% | 46.52% | 38.52% | 14.85% |
| Operating Income Growth % | 68.46% | 29.76% | 3.4% | 30.35% | 16.81% | -44.82% | -44.98% | 46.52% | -1.87% | - |
| EBITDA | 197.59M | 252.12M | 260.23M | 372.58M | 464.35M | 212.58M | 135.67M | 192.77M | 203.97M | 86.29M |
| EBITDA Margin % | 90.96% | 96.6% | 99.7% | 110.62% | 118.5% | 64.16% | 43.7% | 53.74% | 47.98% | 20.35% |
| EBITDA Growth % | 60.71% | 27.6% | 3.22% | 43.17% | 24.63% | -54.22% | -36.18% | 42.09% | 5.81% | -36.34% |
| D&A (Non-Cash Add-back) | 13.98M | 13.87M | 13.87M | 0 | 0 | 5.58M | 21.78M | 25.9M | 40.23M | 23.32M |
| EBIT | 183.6M | 234.21M | 246.36M | 372.58M | 464.35M | 302.74M | 213.25M | 59.6M | 343.56M | 377.44M |
| Net Interest Income | -42.29M | -22.29M | -13.12M | -16.81M | -17.23M | -9.42M | -3.34M | -3.07M | 4.39M | -911K |
| Interest Income | 1.31M | 1.66M | 5.54M | 1.52M | 1.84M | 6.37M | 15.82M | 19.14M | 21.09M | 11.08M |
| Interest Expense | 43.6M | 23.95M | 18.66M | 18.33M | 19.07M | 15.79M | 19.16M | 22.21M | 16.7M | 6.55M |
| Other Income/Expense | -49.33M | -28M | -13.46M | 33.12M | 70.17M | 79.95M | 80.21M | -129.48M | 163.12M | 537.04M |
| Pretax Income | 134.27M▲ 0% | 210.25M▲ 56.6% | 232.9M▲ 10.8% | 354.25M▲ 52.1% | 445.28M▲ 25.7% | 286.95M▼ 35.6% | 194.1M▼ 32.4% | 37.39M▼ 80.7% | 326.86M▲ 774.2% | 600.01M▲ 0% |
| Pretax Margin % | 61.81% | 80.56% | 89.23% | 105.18% | 113.63% | 86.6% | 62.52% | 10.42% | 76.89% | 141.47% |
| Income Tax | 4K | -196.07M | 41.9M | 60.43M | 76.44M | 66.69M | 14.38M | 14M | 55.7M | -266K |
| Effective Tax Rate % | 0% | -93.25% | 17.99% | 17.06% | 17.17% | 23.24% | 7.41% | 37.43% | 17.04% | -0.04% |
| Net Income | 134.14M▲ 0% | 395.06M▲ 194.5% | 157.29M▼ 60.2% | 224.4M▲ 42.7% | 265.85M▲ 18.5% | 213.92M▼ 19.5% | 179.72M▼ 16.0% | 23.39M▼ 87.0% | 271.17M▲ 1059.2% | 504.34M▲ 0% |
| Net Margin % | 61.76% | 151.36% | 60.26% | 66.63% | 67.84% | 64.56% | 57.89% | 6.52% | 63.78% | 118.91% |
| Net Income Growth % | 125.31% | 194.5% | -60.19% | 42.67% | 18.47% | -19.53% | -15.99% | -86.98% | 1059.22% | 944.46% |
| Net Income (Continuing) | 134.27M | 406.33M | 190.99M | 293.81M | 368.84M | 220.26M | 179.72M | 23.39M | 271.17M | 504.34M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 152K | 5.47M | 28.62M | 67.92M | 111.19M | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 1.17▲ 0% | 3.53▲ 201.7% | 1.43▼ 59.5% | 2.02▲ 41.3% | 2.87▲ 42.1% | 2.37▼ 17.4% | 2.20▼ 7.2% | 0.36▼ 83.6% | 3.30▲ 816.7% | 5.94▲ 0% |
| EPS Growth % | 120.75% | 201.71% | -59.49% | 41.26% | 42.08% | -17.42% | -7.17% | -83.64% | 816.67% | 683.1% |
| EPS (Basic) | 1.25 | 3.92 | 1.56 | 2.21 | 3.24 | 3.07 | 2.92 | 0.37 | 4.02 | - |
| Diluted Shares Outstanding | 119.87M | 113.41M | 113.41M | 113.55M | 94.31M | 95.25M | 86.88M | 74.19M | 84.76M | 84.85M |
| Basic Shares Outstanding | 106.94M | 100.85M | 101.15M | 101.32M | 82.06M | 69.64M | 65.44M | 62.73M | 67.39M | 74.16M |
| Dividend Payout Ratio | 0.21% | 0.02% | 0.01% | - | - | - | - | - | - | - |
INVA Balance Sheet
Innoviva, Inc. (INVA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 199.62M | 199.04M | 431.23M | 342.06M | 313.67M | 443.51M | 344.22M | 554.31M | 727.51M | 641.93M |
| Cash & Short-Term Investments | 129.07M | 114.91M | 350.85M | 246.49M | 201.53M | 291.05M | 193.51M | 412.5M | 550.94M | 603.09M |
| Cash Only | 73.34M | 62.42M | 278.1M | 246.49M | 201.53M | 291.05M | 193.51M | 304.96M | 550.94M | 603.09M |
| Short-Term Investments | 55.74M | 52.49M | 72.75M | 0 | 0 | 0 | 0 | 107.53M | 0 | 0 |
| Accounts Receivable | 70.54M | 83.29M | 79.43M | 93.93M | 110.71M | 64.07M | 84.08M | 86.37M | 34.97M | 0 |
| Days Sales Outstanding | 118.53 | 116.47 | 111.07 | 101.8 | 103.12 | 70.58 | 98.84 | 87.88 | 30.02 | 46.63 |
| Inventory | -754K | 0 | 0 | 0 | 0 | 55.9M | 40.74M | 33.73M | 39.17M | 38.84M |
| Days Inventory Outstanding | - | - | - | - | - | 1.48K | 348.71 | 336.35 | 121.57 | 149.47 |
| Other Current Assets | 0 | 0 | 0 | 0 | 70K | 2.93M | 4.26M | 656K | 102.44M | 0 |
| Total Non-Current Assets | 167.72M | 349.15M | 293.59M | 657.51M | 612.72M | 787.99M | 899.29M | 746.75M | 907.65M | 206.3M |
| Property, Plant & Equipment | 209K | 160K | 33K | 28K | 109K | 3.44M | 3.02M | 2.97M | 12.48M | 12.79M |
| Fixed Asset Turnover | 1039.32x | 1631.28x | 7909.58x | 12028.36x | 3595.10x | 96.46x | 102.84x | 120.90x | 34.05x | 55.77x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 26.71M | 17.91M | 17.91M | 17.91M | 17.91M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 252.92M | 230.34M | 208.43M | 182.16M | 175.6M |
| Long-Term Investments | 0 | 0 | 0 | 438.26M | 483.85M | 403.01M | 560.98M | 393.96M | 193.73M | 969.21M |
| Other Non-Current Assets | 167.51M | 152.94M | 139.39M | 125.47M | 128.77M | 101.91M | 87.05M | 111.44M | 501.38M | 716.74M |
| Total Assets | 367.34M▲ 0% | 548.19M▲ 49.2% | 724.83M▲ 32.2% | 999.57M▲ 37.9% | 926.39M▼ 7.3% | 1.23B▲ 32.9% | 1.24B▲ 1.0% | 1.3B▲ 4.6% | 1.64B▲ 25.7% | 1.84B▲ 0% |
| Asset Turnover | 0.59x | 0.48x | 0.36x | 0.34x | 0.42x | 0.27x | 0.25x | 0.28x | 0.26x | 0.27x |
| Asset Growth % | -3.08% | 49.23% | 32.22% | 37.9% | -7.32% | 32.93% | 0.98% | 4.63% | 25.68% | 97% |
| Total Current Liabilities | 34.74M | 5.7M | 5.37M | 6.11M | 5.81M | 134.97M | 38.13M | 236.08M | 49.7M | 62.02M |
| Accounts Payable | 601K | 11K | 10K | 66K | 27K | 2.94M | 6.72M | 2.13M | 4.97M | 0 |
| Days Payables Outstanding | 161.89 | - | - | - | - | 77.77 | 57.5 | 21.26 | 15.41 | 15 |
| Short-Term Debt | 25M | 0 | 0 | 0 | 0 | 96.19M | 0 | 192.03M | 418K | 0 |
| Deferred Revenue (Current) | -19.68M | 0 | 0 | 0 | 0 | 2.09M | 1.28M | 1.13M | 4.27M | 11.07M |
| Other Current Liabilities | 19.68M | 5.22M | 4.71M | 0 | 0 | 2.64M | 0 | 6.44M | 40.04M | 58.34M |
| Current Ratio | 5.75x | 34.92x | 80.29x | 55.98x | 54.02x | 3.29x | 9.03x | 2.35x | 14.64x | 14.64x |
| Quick Ratio | 5.77x | 34.92x | 80.29x | 55.98x | 54.02x | 2.87x | 7.96x | 2.21x | 13.85x | 13.85x |
| Cash Conversion Cycle | - | - | - | - | - | 1.47K | 390.06 | 402.96 | 136.18 | 181.11 |
| Total Non-Current Liabilities | 575.3M | 383.44M | 377.34M | 385.62M | 394.65M | 530.74M | 530.42M | 373.82M | 412.63M | 330.93M |
| Long-Term Debt | 574.36M | 382.86M | 377.12M | 385.52M | 394.65M | 444.18M | 446.23M | 256.32M | 257.73M | 258.1M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 2.38M | 1.64M | 1.18M | 10.87M | 12.77M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 5.77M | 563K | 0 | 31.79M | 104.62M |
| Other Non-Current Liabilities | 940K | 586K | 219K | 106K | 0 | 78.41M | 81.99M | 116.32M | 112.24M | 282.28M |
| Total Liabilities | 610.04M | 389.14M | 382.71M | 391.73M | 400.46M | 665.71M | 568.55M | 609.9M | 462.32M | 392.95M |
| Total Debt | 599.36M | 382.86M | 377.12M | 385.52M | 394.76M | 544.07M | 449.08M | 451.1M | 269.02M | 258.1M |
| Net Debt | 526.03M | 320.44M | 99.02M | 139.03M | 193.23M | 253.02M | 255.56M | 146.13M | -281.92M | -344.99M |
| Debt / Equity | - | 2.41x | 1.10x | 0.63x | 0.75x | 0.96x | 0.67x | 0.65x | 0.23x | 0.23x |
| Debt / EBITDA | 3.03x | 1.52x | 1.45x | 1.03x | 0.85x | 2.56x | 3.31x | 2.34x | 1.32x | 2.99x |
| Net Debt / EBITDA | 2.66x | 1.27x | 0.38x | 0.37x | 0.42x | 1.19x | 1.88x | 0.76x | -1.38x | -1.38x |
| Interest Coverage | 4.21x | 9.78x | 13.20x | 20.32x | 24.35x | 19.17x | 11.13x | 2.68x | 20.57x | 57.62x |
| Total Equity | -242.71M▲ 0% | 159.05M▲ 165.5% | 342.12M▲ 115.1% | 607.84M▲ 77.7% | 525.93M▼ 13.5% | 565.79M▲ 7.6% | 674.96M▲ 19.3% | 691.16M▲ 2.4% | 1.17B▲ 69.7% | 1.44B▲ 0% |
| Equity Growth % | 31.24% | 165.53% | 115.1% | 77.67% | -13.47% | 7.58% | 19.29% | 2.4% | 69.69% | 251.33% |
| Book Value per Share | -2.02 | 1.40 | 3.02 | 5.35 | 5.58 | 5.94 | 7.77 | 9.32 | 13.84 | 17.01 |
| Total Shareholders' Equity | -242.86M | 153.58M | 313.5M | 539.91M | 414.74M | 565.79M | 674.96M | 691.16M | 1.17B | 1.44B |
| Common Stock | 1.02M | 1.01M | 1.01M | 1.01M | 696K | 692K | 633K | 627K | 747K | 0 |
| Retained Earnings | -1.5B | -1.1B | -946.4M | -722M | -456.15M | -204.91M | -25.19M | -1.8M | 269.37M | 0 |
| Treasury Stock | -3.26M | 0 | 0 | 0 | -393.83M | -393.83M | -393.83M | 0 | 0 | 0 |
| Accumulated OCI | -18K | -3K | 27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 152K | 5.47M | 28.62M | 67.92M | 111.19M | 0 | 0 | 0 | 0 | 0 |
INVA Cash Flow Statement
Innoviva, Inc. (INVA) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 141.75M | 223.53M | 257.46M | 313.11M | 363.81M | 201.73M | 141.06M | 188.69M | 196.93M | 196.93M |
| Operating CF Margin % | 65.26% | 85.64% | 98.64% | 92.97% | 92.84% | 60.88% | 45.44% | 52.6% | 46.32% | - |
| Operating CF Growth % | 132.43% | 57.7% | 15.18% | 21.62% | 16.19% | -44.55% | -30.07% | 33.76% | 4.37% | -32.46% |
| Net Income | 134.27M | 406.33M | 190.99M | 293.81M | 368.84M | 220.26M | 179.72M | 23.39M | 271.17M | 504.34M |
| Depreciation & Amortization | 13.98M | 13.87M | 13.87M | 0 | 13.83M | 19.51M | 35.7M | 39.85M | 40.23M | 86.84M |
| Stock-Based Compensation | 9.83M | 3.23M | 2.06M | 1.7M | 2.02M | 7.35M | 5.84M | 6.37M | 9.45M | 18.59M |
| Deferred Taxes | 7.15M | -196.05M | 41.88M | 60.42M | 76.43M | 25.01M | 4.4M | -12.62M | 43.85M | 47.04M |
| Other Non-Cash Items | 4.79M | 12.91M | 5.57M | -28.5M | -80.43M | -77.27M | -59.81M | 138.62M | -143.6M | -523.69M |
| Working Capital Changes | -28.28M | -16.76M | 3.1M | -14.32M | -16.87M | 6.87M | -24.79M | -6.93M | -24.16M | -27.06M |
| Change in Receivables | -23.69M | -12.75M | 3.86M | -14.5M | -16.78M | 9.79M | -20M | -2.29M | -6.95M | -15.38M |
| Change in Inventory | 0 | -3.43M | -664K | 0 | 0 | 280K | -12M | -6.81M | -12.92M | -3.77M |
| Change in Payables | 473K | -590K | -1K | 56K | -39K | 92K | 3.78M | -4.58M | 2.83M | 266K |
| Cash from Investing | -23.24M | 3.52M | -18M | -314.94M | 43.72M | -56.63M | -66.76M | -63.79M | 40.5M | 112.18M |
| Capital Expenditures | 0 | 0 | -12K | -13K | -1.3M | -67K | -411K | -270K | -1.13M | -2.25M |
| CapEx % of Revenue | - | - | 0% | 0% | 0.33% | 0.02% | 0.13% | 0.08% | 0.27% | - |
| Acquisitions | 0 | 0 | 17.99M | -102.86M | -235.81M | -33.2M | 0 | 0 | 0 | 19.94M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -17.99M | 0 | -20.98M | -56.63M | 0 | -3.9M | -929K | 66.02M |
| Cash from Financing | -163.19M | -237.97M | -23.78M | -29.79M | -452.5M | -55.57M | -171.84M | -13.45M | 8.55M | -11.78M |
| Debt Issued (Net) | -63.74M | -230M | -13.75M | 0 | 0 | 66.37M | -96.2M | 0 | -25K | -25K |
| Equity Issued (Net) | -99.63M | -1.93M | 538K | 344K | -393.04M | -8.59M | -75.64M | -13.45M | 8.58M | 8.39M |
| Dividends Paid | -281K | -80K | -11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -99.63M | -3.07M | -89K | -92K | -394.21M | -8.59M | -75.81M | -14.92M | -4.67M | -4.61M |
| Other Financing | 459K | -5.96M | -10.55M | -30.13M | -59.46M | -113.35M | 0 | 0 | 0 | -20.15M |
| Net Change in Cash | -44.68M▲ 0% | -10.92M▲ 75.6% | 215.68M▲ 2075.3% | -31.61M▼ 114.7% | -44.96M▼ 42.2% | 89.52M▲ 299.1% | -97.54M▼ 208.9% | 111.45M▲ 214.3% | 245.98M▲ 120.7% | 284M▲ 0% |
| Free Cash Flow | 141.75M▲ 0% | 223.53M▲ 57.7% | 257.45M▲ 15.2% | 313.1M▲ 21.6% | 362.51M▲ 15.8% | 201.66M▼ 44.4% | 140.65M▼ 30.3% | 188.42M▲ 34.0% | 195.8M▲ 3.9% | 181.34M▲ 0% |
| FCF Margin % | 65.26% | 85.64% | 98.63% | 92.96% | 92.51% | 60.86% | 45.3% | 52.53% | 46.06% | 42.76% |
| FCF Growth % | 133.5% | 57.7% | 15.17% | 21.62% | 15.78% | -44.37% | -30.25% | 33.96% | 3.92% | -7.47% |
| FCF per Share | 1.18 | 1.97 | 2.27 | 2.76 | 3.84 | 2.12 | 1.62 | 2.54 | 2.31 | 2.31 |
| FCF Conversion (FCF/Net Income) | 1.06x | 0.57x | 1.64x | 1.40x | 1.37x | 0.94x | 0.78x | 8.07x | 0.73x | 0.36x |
| Interest Paid | 0 | 0 | 0 | 9.93M | 0 | 11.74M | 0 | 10.36M | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 53.85M | 0 | 11.79M | 0 | 0 |
INVA Key Ratios
Innoviva, Inc. (INVA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | 248.38% | 62.77% | 47.24% | 46.9% | 39.19% | 28.97% | 3.42% | 29.09% | 46.47% |
| Return on Invested Capital (ROIC) | 52.12% | 46.85% | 40.14% | 40.55% | 38.38% | 20.19% | 9.77% | 14.16% | 14.21% | 14.21% |
| Gross Margin | 99.38% | 100% | 100% | 100% | 100% | 95.84% | 86.27% | 89.8% | 72.33% | 76.2% |
| Net Margin | 61.76% | 151.36% | 60.26% | 66.63% | 67.84% | 64.56% | 57.89% | 6.52% | 63.78% | 118.91% |
| Debt / Equity | - | 2.41x | 1.10x | 0.63x | 0.75x | 0.96x | 0.67x | 0.65x | 0.23x | 0.23x |
| Interest Coverage | 4.21x | 9.78x | 13.20x | 20.32x | 24.35x | 19.17x | 11.13x | 2.68x | 20.57x | 57.62x |
| FCF Conversion | 1.06x | 0.57x | 1.64x | 1.40x | 1.37x | 0.94x | 0.78x | 8.07x | 0.73x | 0.36x |
| Revenue Growth | 62.63% | 20.16% | 0% | 29.03% | 16.35% | -15.45% | -6.3% | 15.54% | 18.52% | 13.61% |
INVA SEC Filings & Documents
Innoviva, Inc. (INVA) SEC filings — annual & quarterly reports (10-K, 10-Q)
INVA Frequently Asked Questions
Innoviva, Inc. (INVA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Innoviva, Inc. (INVA) reported $424.1M in revenue for fiscal year 2025. This represents a 271773% increase from $0.2M in 2002.
Innoviva, Inc. (INVA) grew revenue by 18.5% over the past year. This is strong growth.
Yes, Innoviva, Inc. (INVA) is profitable, generating $504.3M in net income for fiscal year 2025 (63.8% net margin).
Dividend & Returns
Innoviva, Inc. (INVA) has a return on equity (ROE) of 29.1%. This is excellent, indicating efficient use of shareholder capital.
Innoviva, Inc. (INVA) generated $181.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More INVA
Innoviva, Inc. (INVA) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates